Skip to content

Feed Screener MCP Methodology

⌘K

EN

Pricing Sign in

InsiderLens

Statistics predict. AI explains.

Insider transactions from public regulatory disclosures, aggregated and enriched with deterministic statistical signals. Not investment advice.

Sources

SEC EDGAR · US
AMF · FR
BAFIN · DE

Product

Ask the record
Help
Methodology
Signal backtests
Terms
Privacy notice
Object to processing

Language

English Español Français

Feed Screener MCP Methodology

English Español Français

Pricing Sign in

Shah Nimesh — Evofem Biosciences, Inc. insider · InsiderLens

/ / Shah Nimesh

Shah Nimesh

10% owner at Evofem Biosciences, Inc. · on record since Dec 18, 2015
10% owner at MARINUS PHARMACEUTICALS, INC. · on record since Dec 18, 2015
10% owner at Tobira Therapeutics, Inc. · on record since Dec 18, 2015
10% owner at Aldeyra Therapeutics, Inc. · on record since Dec 18, 2015
10% owner at Evoke Pharma Inc · on record since Dec 18, 2015
10% owner at Ocera Therapeutics, Inc. · on record since Dec 18, 2015
10% owner at ESPERION THERAPEUTICS INC/MI · on record since Dec 18, 2015
10% owner at Syndax Pharmaceuticals Inc · on record since Mar 2, 2016

Insider trading activity of Shah Nimesh

No transactions on record for Shah Nimesh.

Track record of Shah Nimesh

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of Shah Nimesh

Co-insiders of Shah Nimesh

DOMAIN ASSOCIATESAldeyra Therapeutics, Inc. +7
Kamdar Kim P.Aldeyra Therapeutics, Inc. +7
BLAIR JAMES CAldeyra Therapeutics, Inc. +6
DOVEY BRIAN HAldeyra Therapeutics, Inc. +6
Halak Brian KAldeyra Therapeutics, Inc. +6
TREU JESSE IAldeyra Therapeutics, Inc. +6
VITULLO NICOLEAldeyra Therapeutics, Inc. +6
SCHOEMAKER KATHLEEN KAldeyra Therapeutics, Inc. +5
Domain Partners VI, L.P.Aldeyra Therapeutics, Inc. +4
DP VI Associates, L.P.Aldeyra Therapeutics, Inc. +4
DOMAIN PARTERS VII L PEvofem Biosciences, Inc. +2
DP VII ASSOCIATES LPEvofem Biosciences, Inc. +2
Alta Partners Management VIII, LLCESPERION THERAPEUTICS INC/MI +1
Azan AlainMARINUS PHARMACEUTICALS, INC. +1
BIOTECHNOLOGY VALUE FUND II LPSyndax Pharmaceuticals Inc +1
BIOTECHNOLOGY VALUE FUND L PSyndax Pharmaceuticals Inc +1
Brady Todd CAldeyra Therapeutics, Inc. +1
Buatois EricMARINUS PHARMACEUTICALS, INC. +1

This page republishes public regulatory disclosures.

BVF INC/ILSyndax Pharmaceuticals Inc +1

BVF PARTNERS L P/ILSyndax Pharmaceuticals Inc +1

Domain Partners VIII, L.P.Ocera Therapeutics, Inc. +1

DP VIII Associates, L.P.Ocera Therapeutics, Inc. +1

Gopka AntonMARINUS PHARMACEUTICALS, INC. +1

HEALY JAMESMARINUS PHARMACEUTICALS, INC. +1

LAMPERT MARK NSyndax Pharmaceuticals Inc +1

Legault PierreSyndax Pharmaceuticals Inc +1

MAYLEBEN TIMOTHY MESPERION THERAPEUTICS INC/MI +1

Metzger Michael ASyndax Pharmaceuticals Inc +1

Podlesak DennisSyndax Pharmaceuticals Inc +1

POWELL MICHAELMARINUS PHARMACEUTICALS, INC. +1

QUAKER BIOVENTURES CAPITAL LPOcera Therapeutics, Inc. +1

QUAKER BIO VENTURES LPOcera Therapeutics, Inc. +1

RMI Investments S.a.r.l.Evofem Biosciences, Inc. +1

RusnanoMedInvest LLCEvofem Biosciences, Inc. +1

Sofinnova Management VI, L.L.C.MARINUS PHARMACEUTICALS, INC. +1

Sofinnova Venture Affiliates VI LPMARINUS PHARMACEUTICALS, INC. +1

Sofinnova Venture Partners VI GmbH & Co. KGMARINUS PHARMACEUTICALS, INC. +1

SOFINNOVA VENTURE PARTNERS VI L PMARINUS PHARMACEUTICALS, INC. +1

WEBER ECKARDOcera Therapeutics, Inc. +1

14159 capital (GP), LLCOcera Therapeutics, Inc.

ABERCROMBIE GEORGE BOcera Therapeutics, Inc.

ACACIA RESEARCH CORPEvofem Biosciences, Inc.

Actavis plcTobira Therapeutics, Inc.

Aggarwal GauravOcera Therapeutics, Inc.

AGUIAR ERICOcera Therapeutics, Inc.

Aisling Capital II LPESPERION THERAPEUTICS INC/MI

AISLING CAPITAL PARTNERS, LPESPERION THERAPEUTICS INC/MI

Alfieri MichaelAldeyra Therapeutics, Inc.

Allergan Holdco US, Inc.Tobira Therapeutics, Inc.

Alta Partners VIII, L.P.Evofem Biosciences, Inc.

Concerned by this data? Exercise your right to object →

No transactions on record. Reset filters